Influence of age and histology on outcome in adult non-hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): A report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

Lazarus, Hillard M.; Carreras, Jeanette; Rowlings, Philip; Boudreau, Christian; Loberiza Jr., Fausto R.; Armitage, James O.; Bolwell, Brian J.; Freytes, César 0.; Gale, Robert Peter; Gibson, John; Hale, Gregory A.

Title: Influence of age and histology on outcome in adult non-hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): A report from The Center For International Blood & Marrow Transplant Research (CIBMTR)
Creator: Lazarus, Hillard M.; Carreras, Jeanette; Rowlings, Philip; Boudreau, Christian; Loberiza Jr., Fausto R.; Armitage, James O.; Bolwell, Brian J.; Freytes, César 0.; Gale, Robert Peter; Gibson, John; Hale, Gregory A.
Relation: Biology of Blood and Marrow Transplantation Vol. 14, Issue 12, p. 1323-1333
Relation: doi:10.1016/j.bbmt.2008.09.008
Publisher: Elsevier
Resource Type: journal article
Date: 2008
Description: To compare the clinical outcomes of older (age ≥55 years) non-Hodgkin lymphoma (NHL) patients with younger NHL patients (<55 years) receiving autologous hematopoietic cell transplantation (HCT) while adjusting for patient-, disease-, and treatment-related variables, we compared autologous HCT outcomes in 805 NHL patients aged ≥55 years to 1949 NHL patients <55 years during the years 1990–2000 using data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). In multivariate analysis, older patients with aggressive histologies were 1.86 times (95% confidence interval [CI] 1.43-2.43, P<.001) more likely than younger patients to experience treatment-related mortality (TRM). Relative death risks were 1.33 times (CI 1.04-1.71, P=.024) and 1.50 times (CI 1.33-16.9, P<.001) higher in older compared to younger patients with follicular grade I/II and aggressive histologies, respectively. Autologous HCT in older NHL patients is feasible, but most disease-related outcomes are statistically inferior to younger patients. Studies addressing supportive care particular to older patients, who are most likely to benefit from this approach, are recommended.
Subject: non-Hodgkin lymphoma; autologous HCT; relapse; second complete remission; elderly
Identifier: uon:5007
Identifier: http://hdl.handle.net/1959.13/42867
Identifier: ISSN:1083-8791
Reviewed

Hits: 8677
Visitors: 8975
Downloads: 0

		Thumbnail	File	Description	Size	Format